Amneal Pharmaceuticals Announces Corporate Business Development Team  
12/6/2011 8:12:51 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, LLC, a fast-growing manufacturer of generic drugs, today announced key additions to its corporate business development team:

Joseph Todisco has joined Amneal as Senior Vice President of Global Corporate Strategy & Business Development. He is responsible for the growth of the company’s domestic generic business as well as the development of Amneal’s global presence through partnerships, mergers and acquisitions, and the strategic deployment of existing commercial assets. Mr. Todisco was most recently Vice President of Business Development at Ranbaxy, Inc. where he was responsible for the firm’s U.S. business strategy. Prior to Ranbaxy, he held various positions in marketing, R&D and business development with Par Pharmaceutical Companies, Inc. Mr. Todisco received an MBA from Fordham University’s Graduate School of Business and a BA in economics from Georgetown University.